Hinze-Selch D, Schuld A, Kraus T, Kühn M, Uhr M, Haack M, Pollmächer T
Max Planck Institute of Psychiatry, Munich, Germany.
Neuropsychopharmacology. 2000 Jul;23(1):13-9. doi: 10.1016/S0893-133X(00)00089-0.
Leptin, tumor necrosis factor-alpha (TNF-alpha), and soluble TNF receptors are involved in weight regulation. Antipsychotic agents, such as clozapine, induce weight gain and increase circulating levels of these cytokines. To assess whether obesity-inducing antidepressants have a similar effect, we measured plasma cytokine levels in depressive inpatients during the first six weeks of treatment with tricyclic agents (amitriptyline or nortriptyline, n = 12), with paroxetine (n = 10), or without medication (n = 14). There was an increase in the body mass index at week 6 of treatment with the tricyclics, which was preceded by a significant increase in soluble TNF receptor p75 plasma levels. Circulating levels of leptin were not affected. Paroxetine and drug-free treatment did not affect any of these parameters. We conclude that weight gain induced by psychotropic agents may occur without increased circulating levels of leptin. However, activation of the TNF-alpha system might be an early and sensitive marker of ensuing weight gain.
瘦素、肿瘤坏死因子-α(TNF-α)和可溶性TNF受体参与体重调节。抗精神病药物,如氯氮平,会导致体重增加并使这些细胞因子的循环水平升高。为了评估致肥胖的抗抑郁药是否有类似作用,我们测量了三环类药物(阿米替林或去甲替林,n = 12)、帕罗西汀(n = 10)治疗的抑郁症住院患者或未用药患者(n = 14)在治疗的前六周的血浆细胞因子水平。三环类药物治疗第6周时体重指数增加,在此之前可溶性TNF受体p75血浆水平显著升高。瘦素的循环水平未受影响。帕罗西汀治疗和未用药治疗对这些参数均无影响。我们得出结论,精神药物引起的体重增加可能在瘦素循环水平未升高的情况下发生。然而,TNF-α系统的激活可能是随后体重增加的一个早期且敏感的标志物。